Directorate Change

VECTURA GROUP PLC (the "Company")

- Directorate Change -

Chippenham, UK - 31 October 2018: Vectura Group plc (LSE: VEC) ("Vectura"), an industry-leading inhaled product formulation, device design and development business, today announces the following:

Non-Executive Director Changes

As announced in April 2018, alongside Anne Whitaker's appointment, Frank Condella, Non-Executive Director and Vice Chairman, is stepping down from the Board of Vectura. This change takes effect on 31st October 2018.

Bruno Angelici, Vectura's Chairman commented: "I would like to thank and recognise the significant input Frank has made to the business; firstly at Skyepharma and more recently, to the Vectura Group. He has provided valuable contributions since joining in 2006, initially in an executive role and subsequently in non-executive roles. We all wish him the very best in his future endeavours."

Appointment of Remuneration Committee Chair

The Board is pleased to announce, pursuant to Listing Rule 9.6.11, the appointment of Juliet Thompson as Chair of the Company's Remuneration Committee, with effect from 1st January 2019, when Sue Foden will be standing down from the role. Sue will remain on the Board and as a member of the Nominations Committee as well as continuing her role as Senior Independent Director (SID).

This change is part of an-ongoing Board succession planning exercise in respect of non-executive directors.

- Ends -

Enquiries